United States · Series A startup

Who invested in Maverix Biomics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechSoftware

Funding summaryUpdated 26 Oct 2026

$6.0Mraised across 1 round since 2014, from 1 source

Latest round
Series A, $6.0MJan 2014
Investors
4
See who backed them

The rounds

  1. Jan 2014
    Series A$6.0M

    From a historical funding recordSEC filing: $8.0M sold, first sale Dec 2013

Founders and team

From the SEC filings it signed: 5 on the team.

  • David Pak Lee MandelkernExecutive Officer, Director, Promoteri
  • Gordon RingoldDirector, Promoteri
  • Patricia Pak Lee ChanExecutive Officeri
  • Paul Pak Lee PickeringExecutive Officeri
  • Todd Michael Johnson LoweExecutive Officer, Director, Promoteri

Everyone who backed them

M VenturesCorporate VC1round
Andrew Yangno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Maverix Biomics

Who invested in Maverix Biomics?

Maverix Biomics's investors include M Ventures, Asset Management Ventures, Andreas Bechtolsheim and Andrew Yang.

How much has Maverix Biomics raised?

Maverix Biomics has raised $6.0M across 1 round since 2014.

When did Maverix Biomics last raise?

Maverix Biomics's most recent round was a Series A of $6.0M in Jan 2014.

What was Maverix Biomics's biggest round?

Its most recent round, $6.0M in Jan 2014, is also its largest on record.

Who backed Maverix Biomics first?

Maverix Biomics's first round on record, in Jan 2014, was backed by M Ventures, Asset Management Ventures and Andreas Bechtolsheim and 1 others.

What stage is Maverix Biomics at?

Maverix Biomics's latest named round is a Series A, in Jan 2014.

Where is Maverix Biomics based?

Maverix Biomics is based in the United States.

Companies like Maverix Biomics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.